DBCO NHS ester
Cat. # | Quantity | Price | Lead time | Buy this product |
---|---|---|---|---|
34720 | 10 mg | $60.00 | in stock | |
44720 | 25 mg | $95.00 | in stock | |
54720 | 50 mg | $145.00 | in stock | |
64720 | 100 mg | $210.00 | in stock | |
94720 | 1 g |
$1190.00
|
in stock | |
K4720 | 5 g |
$3570.00
|
5 days | |
N4720 | 25 g |
please inquire
|
21 days |
Dibenzocyclooctyne (ADIBO, DBCO) is one of the most reactive cycloalkynes for strain promoted alkyne azide cycloaddition (SPAAC) – a copper-free click chemistry reaction.
This is an amine-reactive NHS ester that provides easy attachment of the reactive moiety to almost any primary or secondary amine group, such as that of protein, peptide, or small molecule amine.
DBCO reacts instantly with azides. The rate of the reaction is much higher than that of copper-catalyzed reaction, and reactions with many other cyclooctynes. Unlike some other cyclooctynes, DBCO does not react with tetrazines - this allows to carry out orthogonal conjugation of azides with DBCO, and trans-cyclooctenes with tetrazines.
Customers also purchased with this product
Ascorbic acid
Ascorbic acid for the reduction of Cu(II)-TBTA complex.Copper(II)-TBTA complex, 10 mM in 55% aq. DMSO
Catalyst for bioconjugate synthesis by Click Chemistry.Cyanine3 NHS ester
Amine-reactive Cyanine3 dye NHS ester.General properties
Appearance: | off white solid |
Mass spec M+ increment: | 315.1 |
Molecular weight: | 430.45 |
CAS number: | 1384870-47-6 |
Molecular formula: | C25H22N2O5 |
IUPAC name: | 6-{2-Azatricyclo[10.4.0.04,9]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl}-6-oxohexanamide |
Solubility: | good in DCM, DMF, DMSO |
Quality control: | NMR 1H, HPLC-MS (95%) |
Storage conditions: | Storage: 12 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate. |
MSDS: | Download |
Product specifications |
Product citations
- Adams, M.R.; Moody, C.T.; Sollinger, J.L.; Brudno, Y. Extracellular Matrix-Anchored Click Motifs for Specific Tissue Targeting. Molecular Pharmaceutics, 2020, 17(2), 392–403. doi: 10.1021/acs.molpharmaceut.9b00589
- Alshanski, I.; Blaszkiewicz, J.; Mervinetsky, E.; Rademann, J.; Yitzchaik, S.; Hurevich, M. Sulfation Patterns of Saccharides and Heavy Metal Ions Binding. Chemistry, 2019, 25(52), 12083–12090. doi: 10.1002/chem.201901538
- Andersen, V.L.; Vinther, M.; Kumar, R.; Ries, A.; Wengel, J.; Nielsen, J.S.; Kjems, J. A self-assembled, modular nucleic acid-based nanoscaffold for multivalent theranostic medicine. Theranostics, 2019, 9(9), 2662–2677. doi: 10.7150/thno.32060
